Press Releases
Search
-
05 Sep 2018
First-Half 2018 Results
Strong sales dynamic, with sales up 10.4% over the first half at constant exchange rates and scope of consolidation: €1,169 million in sales Up 3.1% as reported Contributive operating income before no...
-
18 Jul 2018
Second-Quarter 2018 Business Review
Strong sales dynamic confirmed in second quarter, leading to sales up 10.4% over the first half at constant exchange rates and scope of consolidation: €1,169 million in sales Up 3.1% as reported Growt...
-
12 Jun 2018
NEPHROCHECK® Biomarkers TIMP-2 and IGFBP7 Included in Acute Dialysis Quality Initiative Recommendations
The biomarkers in the NEPHROCHECK® test, an FDA-cleared and CE-marked urine test that indicates kidney stress in advance of acute kidney injury (AKI), have been included in a second set of consensus r...
-
31 May 2018
bioMérieux launches ENDOZYME® II GO, an innovative test for the detection of endotoxins in pharmaceutical microbiology control
bioMérieux, a world leader in the field of industrial microbiological control, announces the launch of ENDOZYME® II GO, a new endotoxin test in the bioMérieux ENDONEXTTM range of recombinant horseshoe...
-
02 May 2018
NEPHROCHECK Biomarkers TIMP-2 and IGFBP7 Included in Groundbreaking Consensus Statement of Best Practices to Enhance Recovery after Heart Surgery
Marcy l’Étoile (France) and San Diego (California) - May 2nd, 2018 – The biomarkers in the NEPHROCHECK test, an FDA-cleared and CE-marked urine test that indicates kidney stress in advance of acute ki...
-
23 Apr 2018
bioMérieux and the University of Antwerp award scholarships to three healthcare professionals for their commitment to improve antibiotic use in order to combat antimicrobial resistance
Marcy l'Étoile (France) – Antwerp (Belgium) – April 23, 2018 – bioMérieux, a world leader in the field of in vitro diagnostics, and the Laboratory of Medical Microbiology at the University of Antwerp ...
-
19 Apr 2018
bioMérieux submits for FDA Clearance of the BIOFIRE® FILMARRAY® Pneumonia Panel
bioMérieux, a world leader in the field of in vitro diagnostics, announces that BioFire Diagnostics, its molecular biology affiliate, has submitted to the Food and Drug Administration for 510(k) clear...
-
19 Apr 2018
bioMérieux – First-Quarter 2018 Business Review
Strong sales dynamic in first-quarter 2018, with sales up 12.5% at constant exchange rates and scope of consolidation: €587 million in sales Up 3.4% as reported Growth driven by molecular biology in t...
-
04 Apr 2018
bioMérieux reinforces its offering of High Medical Value immunoassay biomarkers with the acquisition of Astute Medical
bioMérieux, a world leader in the field of in vitro diagnostics, announces today the acquisition of Astute Medical Inc., a company dedicated to improving the diagnosis of high-risk medical conditions ...
-
28 Feb 2018
2017 Financial Results
Excellent sales momentum in 2017 with a 10.2% increase in sales, at constant exchange rates and scope of consolidation: €2,288 million in sales Up 8.8% as reported Strong 12.4% increase in contributiv...
-
23 Jan 2018
bioMérieux – Fourth-Quarter 2017 Business Review
Excellent sales momentum in 2017 with 10.2% growth in sales, at constant exchange rates and scope of consolidation: €2,288 million in sales Up 8.8% as reported Growth underpinned by all strategic prod...
-
15 Jan 2018
CNES and bioMérieux extend their collaboration on Aquapad, a unique water quality testing tool
Monday 15 January in Marcy l’Étoile (near Lyon), Proxima mission astronaut Thomas Pesquet detailed, during a conference, lessons learned from the Aquapad experiment he performed on the International S...
-
15 Dec 2017
Alexandre Mérieux appointed Chairman and CEO of bioMérieux
The Board of Directors of bioMérieux met today and approved the appointment of Alexandre Mérieux as Chairman and CEO of the Company, taking effect immediately. After serving as Deputy CEO of bioMérieu...
-
18 Oct 2017
bioMérieux – Business review for the nine months ended September 30, 2017
Solid growth in sales, up 10.7% at constant exchange rates and scope of consolidation €1,674 million in sales Up 10.8% as reported In microbiology, growth accelerated to nearly 8% Contribution from al...
-
30 Aug 2017
bioMérieux – First-Half 2017 Results
Solid sales dynamic, with sales up 11.3% over the first half at constant exchange rates and scope of consolidation: €1,134 million in sales Up 13.3% as reported 30-bp improvement in contributive opera...